McKesson Corporation $MCK Stock Acquired by Vise Technologies Inc.

Vise Technologies Inc. increased its stake in McKesson Corporation (NYSE:MCK) by 11.5% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 8,393 shares of the company’s stock after purchasing an additional 866 shares during the period. Vise Technologies Inc.’s holdings in McKesson were worth $7,166,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. BlackRock Inc. acquired a new stake in shares of McKesson in the 2nd quarter valued at about $8,156,743,000. Bank of America Corp DE acquired a new position in shares of McKesson during the second quarter worth about $998,896,000. Legal & General Group Plc acquired a new position in shares of McKesson during the second quarter worth about $656,566,000. The Manufacturers Life Insurance Company bought a new position in shares of McKesson during the second quarter worth about $651,462,000. Finally, Bank of New York Mellon Corp bought a new position in shares of McKesson during the second quarter worth about $599,060,000. Institutional investors own 85.07% of the company’s stock.

Analysts Set New Price Targets

MCK has been the topic of a number of recent research reports. Citigroup lifted their target price on McKesson from $945.00 to $1,000.00 and gave the company a “buy” rating in a research report on Friday, July 24th. Wells Fargo & Company upped their price target on McKesson from $812.00 to $933.00 and gave the stock an “equal weight” rating in a research report on Tuesday, August 11th. Argus raised their price target on shares of McKesson from $850.00 to $970.00 and gave the stock a “buy” rating in a research note on Thursday, September 3rd. UBS Group lifted their price objective on shares of McKesson from $1,080.00 to $1,200.00 and gave the company a “buy” rating in a report on Friday, October 16th. Finally, TD Cowen boosted their price objective on shares of McKesson from $989.00 to $1,006.00 and gave the stock a “buy” rating in a research report on Thursday, August 6th. Fifteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $997.12.

McKesson Price Performance

Shares of NYSE MCK opened at $1,001.05 on Tuesday. The stock has a market capitalization of $116.71 billion, a price-to-earnings ratio of 26.79, a PEG ratio of 1.91 and a beta of 0.30. The business has a 50-day moving average of $925.32 and a 200-day moving average of $863.78. McKesson Corporation has a fifty-two week low of $723.68 and a fifty-two week high of $1,030.27.

McKesson (NYSE:MCK) last released its earnings results on Wednesday, August 5th. The company reported $9.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.56 by $0.37. McKesson had a negative return on equity of 253.21% and a net margin of 1.12%. The business had revenue of $105.38 billion for the quarter, compared to the consensus estimate of $103.88 billion. During the same quarter in the previous year, the business earned $8.26 earnings per share. McKesson’s quarterly revenue was up 7.7% on a year-over-year basis. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. On average, sell-side analysts expect that McKesson Corporation will post 44.71 EPS for the current year.

McKesson Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, January 4th. Shareholders of record on Tuesday, December 1st will be given a dividend of $0.94 per share. The ex-dividend date of this dividend is Tuesday, December 1st. This represents a $3.76 annualized dividend and a dividend yield of 0.4%. McKesson’s payout ratio is 10.06%.

Insiders Place Their Bets

In other news, CAO Napoleon B. Rutledge, Jr. sold 111 shares of the stock in a transaction that occurred on Tuesday, September 8th. The stock was sold at an average price of $891.45, for a total value of $98,950.95. Following the completion of the sale, the chief accounting officer owned 521 shares of the company’s stock, valued at approximately $464,445.45. This represents a 17.56% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Francisco Fraga sold 800 shares of the firm’s stock in a transaction on Thursday, October 15th. The shares were sold at an average price of $995.80, for a total transaction of $796,640.00. Following the completion of the transaction, the executive vice president directly owned 5,423 shares of the company’s stock, valued at $5,400,223.40. This represents a 12.86% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,212 shares of company stock valued at $1,164,182 in the last 90 days. 0.06% of the stock is currently owned by insiders.

McKesson Company Profile

McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and medical products to pharmacies, hospitals, health systems, physicians and other healthcare providers. The company also provides technology, data and business solutions designed to support prescription management, pharmacy operations and patient care.

McKesson’s principal activities include pharmaceutical distribution, medical-surgical supply distribution, specialty pharmaceutical services and oncology care support.